| Folic acid and the decline in neural tube defects in Arkansas. | |
| | |
MedLine Citation:
|
PMID: 17487022 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Folic acid has been shown to reduce the risk of pregnancies affected by neural tube defects (NTDs) by as much as 70%. Cereal grains sold in the U.S. have been fortified with folic acid since 1998. The Arkansas Reproductive Health Monitoring System and the Arkansas Folic Acid Coalition have encouraged use of folic acid and monitored the impact of increased consumption of folic acid among Arkansans. NTDs in Arkansas have declined 40% since intervention programs were implemented. The greatest decline has been observed among white and Hispanic women. Efforts to encourage folic acid consumption should continue to target Arkansas women. NTDs include anencephaly and spina bifida. These birth defects result from incomplete closure of the fetal neural tube during the first month of pregnancy. Infants with anencephaly are born without all or most of their brain and die within a few days of life. Infants with spina bifida have varying degrees of impairment ranging from little noticeable disability to severe, lifelong disability. Folic acid, when taken in supplement form has been shown to reduce the risk of a pregnancy affected by a neural tube defect by as much as 70%. As a result of this finding, the U.S. Federal Drug Administration mandated that cereal grains sold in this country be fortified with at least 140 mcg of folic acid per 100 grams of grain by January 1, 1998. Prior to mandatory fortification, the March of Dimes and the U.S. Public Health Service released statements encouraging all women of reproductive age who are capable of becoming pregnant to take 400 mcg 'of synthetic folic acid daily. The Arkansas Reproductive Health Monitoring System (ARHMS) has monitored rates of NTDs in Arkansas since 1980. ARHMS is the lead agency of the Arkansas Folic Acid Coalition whose mission is to encourage folic acid use among all Arkansas women of reproductive age. In this report, we summarize efforts by ARHMS and the Arkansas Folic Acid Coalition to increase the awareness and use of folic acid in Arkansas, show how the rates of NTDs in the state have declined over the past 10 years, and estimate the direct health care and productivity cost savings to Arkansans over that time. |
| | |
Authors:
|
Bridget S Mosley; Charlotte A Hobbs; Bettye S Flowers; Veronica Smith; James M Robbins |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The Journal of the Arkansas Medical Society Volume: 103 ISSN: 0004-1858 ISO Abbreviation: J Ark Med Soc Publication Date: 2007 Apr |
Date Detail:
|
Created Date: 2007-05-09 Completed Date: 2007-05-29 Revised Date: 2007-12-03 |
Medline Journal Info:
|
Nlm Unique ID: 7503069 Medline TA: J Ark Med Soc Country: United States |
Other Details:
|
Languages: eng Pagination: 247-50 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anencephaly
/
epidemiology Arkansas / epidemiology Dietary Supplements* Folic Acid / therapeutic use* Health Education Humans Neural Tube Defects / epidemiology*, prevention & control Spinal Dysraphism / epidemiology |
| Grant Support | |
ID/Acronym/Agency:
|
U50/CCU613236-02/CC/CDC HHS |
| Chemical | |
Reg. No./Substance:
|
59-30-3/Folic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism de...
Next Document: Improving our patients' oral health: the role of a triclosan/copolymer/ fluoride dentifrice.